NewLeaf Symbiotics

NewLeaf Symbiotics was formed in 2012 to develop and commercialize one of the most prevalent, beneficial bacteria found in nature: PPFMs (Pink Pigmented Facultative Methylotrophs). NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria. NewLeaf Symbiotics has also filed its own related patents, and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.
Company Growth (employees)
Type
Private
HQ
St. Louis, US
Founded
1999
Size (employees)
24 (est)+5%
NewLeaf Symbiotics was founded in 1999 and is headquartered in St. Louis, US

Key People at NewLeaf Symbiotics

Thomas Laurita

Thomas Laurita

President and CEO
Stephen Kahn

Stephen Kahn

Senior VP and CFO
Gregg Bogosian

Gregg Bogosian

Chief Scientist
Marcus Jones

Marcus Jones

Vice President, Product Development
Jim Budzynski

Jim Budzynski

VP Business Development and CTO

NewLeaf Symbiotics Office Locations

NewLeaf Symbiotics has an office in St. Louis
St. Louis, US (HQ)
1005 North Warson Road

NewLeaf Symbiotics Data and Metrics

Summary Metrics

Founding Date

1999

Total Funding

$27.6 m

Latest funding size

$3.6 m

Time since last funding

about 2 months

Investors

NewLeaf Symbiotics's latest funding round in March 2017 was reported to be $3.6 m. In total, NewLeaf Symbiotics has raised $27.6 m

NewLeaf Symbiotics Company Life and Culture

You may also be interested in